Patients with systemic autoimmune rheumatic diseases remain at risk for hospitalisation for COVID-19 infection in the Omicron era (2022–2024): a retrospective cohort study

Patients with systemic autoimmune rheumatic diseases remain at risk for hospitalisation for COVID-19 infection in the Omicron era (2022–2024): a retrospective cohort study

Objective To investigate the risk factors for severe acute COVID-19 outcomes in the Omicron era among individuals with systemic autoimmune rheumatic diseases (SARDs).Methods We identified patients with confirmed SARDs and COVID-19 (positive PCR and/or antigen test) from 1 September 2022 to 15 March...

Full description

Bibliographic Details
Main Authors: Zachary S Wallace, Andrew King, Jeffrey A Sparks, Naomi J Patel, Kathleen MM Vanni, Grace Qian, Xiaosong Wang, Emily N Kowalski, Buuthien Hang, Shruthi Srivatsan, Katarina J Bade, Alene A Saavedra, Zachary K Williams, Jennifer S Hanberg, Kevin T Mueller, Colebrooke Johnson, Madison Negron
Format: Article
Language:English
Published: BMJ Publishing Group 2025-03-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/11/1/e005114.full

Internet

https://rmdopen.bmj.com/content/11/1/e005114.full

Similar Items